Figures computed from official regulatory filings — .
Analysttarget 7 USD (+263%) · consensus 4.75/5 · 4 buy · 0 hold · 0 sell
Ownershipinsiders 10.75% · institutions 15.56% · short 9.1% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Inmune Bio, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
INmune Bio Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company's development programs include INKmune, which is in Phase 1 for the treatment of patients with high-risk myelodysplastic syndrome; and INB03, which is in Phase II for the treatment of breast cancer. It provides XPro1595 for the treatment of Alzheimer's disease and treatment resistant depression; and CORDstrom, a cell suspension for intravenous infusion or injection comprising aseptic, allogeneic, and pooled HucMSCs. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; GOSH; and University of Pittsburg. The company was incorporated in 2015 and is headquartered in Boca Raton, Florida.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
47 buys22 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Clark Ronnie Duane | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| SAPIRSTEIN JAMES | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Juda Scotttrack record | OtherD (derivative) | $1.9K | SEC |
| Moss David Jtrack record | OtherD (derivative) | $1.1K | SEC |
| Lowdell Mark William | OtherD (derivative) | $901.4 | SEC |
| Lowdell Mark William | Exercise | $10.1K | SEC |
| Moss David Jtrack record | Exercise | $12.6K | SEC |
| Juda Scotttrack record | Exercise | $20.7K | SEC |
| Moss David Jtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Lowdell Mark William | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Ellspermann Cory Randall | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Schroeder Timothy j | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Ganjei James Kelly | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| ALLEN MARCIA | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Juda Scotttrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Moss David Jtrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Schroeder Timothy j | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Lowdell Mark William | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Juda Scotttrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Juda Scotttrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Juda Scotttrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Ganjei James Kelly | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| ALLEN MARCIA | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Moss David Jtrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Lowdell Mark William | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |